BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37994246)

  • 1. Employing Noble Metal-Porphyrins to Engineer Robust and Highly Active Single-Atom Nanozymes for Targeted Catalytic Therapy in Nasopharyngeal Carcinoma.
    Wang D; Wang J; Gao XJ; Ding H; Yang M; He Z; Xie J; Zhang Z; Huang H; Nie G; Yan X; Fan K
    Adv Mater; 2024 Feb; 36(7):e2310033. PubMed ID: 37994246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Edge-Site Engineering of Defective Fe-N
    Zhang R; Xue B; Tao Y; Zhao H; Zhang Z; Wang X; Zhou X; Jiang B; Yang Z; Yan X; Fan K
    Adv Mater; 2022 Sep; 34(39):e2205324. PubMed ID: 35953446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermal Atomization of Platinum Nanoparticles into Single Atoms: An Effective Strategy for Engineering High-Performance Nanozymes.
    Chen Y; Wang P; Hao H; Hong J; Li H; Ji S; Li A; Gao R; Dong J; Han X; Liang M; Wang D; Li Y
    J Am Chem Soc; 2021 Nov; 143(44):18643-18651. PubMed ID: 34726407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus infection and nasopharyngeal carcinoma.
    Tsao SW; Tsang CM; Lo KW
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bridging the Catalytic Turnover Gap Between Single-Atom Iron Nanozymes and Natural Enzymes by Engineering the First and Second Shell Coordination.
    Choi D; Jung H; Im J; Yi SY; Kim S; Lee D; Park S; Lee C; Kim J; Han JW; Lee J
    Adv Mater; 2024 Mar; 36(13):e2306602. PubMed ID: 38091378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasopharyngeal Carcinoma Progression: Accumulating Genomic Instability and Persistent Epstein-Barr Virus Infection.
    Liu X; Deng Y; Huang Y; Ye J; Xie S; He Q; Chen Y; Lin Y; Liang R; Wei J; Li Y; Zhang J
    Curr Oncol; 2022 Aug; 29(9):6035-6052. PubMed ID: 36135044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultralow Ru Single Atoms Confined in Cerium Oxide Nanoglues for Highly-Sensitive and Robust H
    Yuan M; Li Q; Wu Z; Zhu H; Gao Y; Zhou M; Luo X; Wang M; Cheng C
    Small; 2023 Dec; 19(52):e2304532. PubMed ID: 37649195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanozymes-Engineered Metal-Organic Frameworks for Catalytic Cascades-Enhanced Synergistic Cancer Therapy.
    Liu C; Xing J; Akakuru OU; Luo L; Sun S; Zou R; Yu Z; Fang Q; Wu A
    Nano Lett; 2019 Aug; 19(8):5674-5682. PubMed ID: 31361142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in colorimetric sensors based on nanozymes with peroxidase-like activity.
    Chi Z; Wang Q; Gu J
    Analyst; 2023 Jan; 148(3):487-506. PubMed ID: 36484756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ru(III)-Based Metal-Organic Gels: Intrinsic Horseradish and NADH Peroxidase-Mimicking Nanozyme.
    He L; Li Y; Wu Q; Wang DM; Li CM; Huang CZ; Li YF
    ACS Appl Mater Interfaces; 2019 Aug; 11(32):29158-29166. PubMed ID: 31313570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytolytic virus activation therapy and treatment monitoring for Epstein-Barr virus associated nasopharyngeal carcinoma in a mouse tumor model.
    Novalić Z; Verkuijlen SAWM; Verlaan M; Eersels JLH; de Greeuw I; Molthoff CFM; Middeldorp JM; Greijer AE
    J Med Virol; 2017 Dec; 89(12):2207-2216. PubMed ID: 28853217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updates on Epstein-Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV.
    Ahmed N; Abusalah MAHA; Farzand A; Absar M; Yusof NY; Rabaan AA; AlSaihati H; Alshengeti A; Alwarthan S; Alsuwailem HS; Alrumaih ZA; Alsayyah A; Yean CY
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boosting the peroxidase-like activity of Pt nanozymes by a synergistic effect of Ti
    Geng H; Li Z; Liu Q; Yang Q; Jia H; Chen Q; Zhou A; He W
    Dalton Trans; 2022 Aug; 51(31):11693-11702. PubMed ID: 35851631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
    Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM
    Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating the local coordination environment of cobalt single-atomic nanozymes for enhanced catalytic therapy against bacteria.
    Zhang J; Sun B; Zhang M; Su Y; Xu W; Sun Y; Jiang H; Zhou N; Shen J; Wu F
    Acta Biomater; 2023 Jul; 164():563-576. PubMed ID: 37004783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus microRNA BART10-3p promotes dedifferentiation and proliferation of nasopharyngeal carcinoma by targeting ALK7.
    Luo WJ; He SW; Zou WQ; Zhao Y; He QM; Yang XJ; Guo R; Mao YP
    Exp Biol Med (Maywood); 2021 Dec; 246(24):2618-2629. PubMed ID: 34424090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface Ligand Engineering Ruthenium Nanozyme Superior to Horseradish Peroxidase for Enhanced Immunoassay.
    Fan H; Zheng J; Xie J; Liu J; Gao X; Yan X; Fan K; Gao L
    Adv Mater; 2024 Mar; 36(10):e2300387. PubMed ID: 37086206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anoikis resistance and immune escape mediated by Epstein-Barr virus-encoded latent membrane protein 1-induced stabilization of PGC-1α promotes invasion and metastasis of nasopharyngeal carcinoma.
    Liao C; Li M; Chen X; Tang C; Quan J; Bode AM; Cao Y; Luo X
    J Exp Clin Cancer Res; 2023 Oct; 42(1):261. PubMed ID: 37803433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma: A Brief Review.
    Xue F; He X
    Methods Mol Biol; 2020; 2204():99-107. PubMed ID: 32710318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of nasal and nasopharyngeal swab collection for the detection of Epstein-Barr virus in nasopharyngeal carcinoma.
    Coghill AE; Wang CP; Verkuijilen SAWM; Yu KJ; Hsu WL; Middeldorp JM; Hildesheim A
    J Med Virol; 2018 Jan; 90(1):191-195. PubMed ID: 28833336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.